Literature DB >> 25735191

Glucose- and pH-responsive nanogated ensemble based on polymeric network capped mesoporous silica.

Lei Tan1, Mei-Yan Yang1, Hai-Xia Wu1,2, Zhao-Wen Tang1, Jian-Yun Xiao1, Chuan-Jun Liu1, Ren-Xi Zhuo1.   

Abstract

In this paper, a glucose and pH-responsive release system based on polymeric network capped mesoporous silica nanoparticles (MSN) has been presented. The poly(acrylic acid) (PAA) brush on MSN was obtained through the surface-initiated atom transfer radical polymerization (SI-ATRP) of t-butyl acrylate and the subsequent hydrolysis of the ester bond. Then the PAA was glycosylated with glucosamine to obtain P(AA-AGA). To block the pore of silica, the P(AA-AGA) chains were cross-linked through the formation of boronate esters between 4,4-(ethylenedicarbamoyl)phenylboronic acid (EPBA) and the hydroxyl groups of P(AA-AGA). The boronate esters disassociated in the presence of glucose or in acidic conditions, which lead to opening of the mesoporous channels and the release of loaded guest molecules. The rate of release could be tuned by varying the pH or the concentration of glucose in the environment. The combination of two stimuli exhibited an obvious enhanced release capacity in mild acidic conditions (pH 6.0).

Entities:  

Keywords:  controlled drug release; core−shell nanoparticles; glucose response; glycosylated polymer; mesoporous silica nanoparticles; pH response

Mesh:

Substances:

Year:  2015        PMID: 25735191     DOI: 10.1021/acsami.5b00631

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  13 in total

Review 1.  pH-Responsive Mesoporous Silica and Carbon Nanoparticles for Drug Delivery.

Authors:  Miguel Gisbert-Garzarán; Miguel Manzano; María Vallet-Regí
Journal:  Bioengineering (Basel)       Date:  2017-01-18

2.  PNIPAAM modified mesoporous hydroxyapatite for sustained osteogenic drug release and promoting cell attachment.

Authors:  Tao Wu; Lei Tan; Ning Cheng; Qi Yan; Yu-Feng Zhang; Chuan-Jun Liu; Bin Shi
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2016-01-08       Impact factor: 7.328

Review 3.  Mesoporous Silica Nanoparticles: A Comprehensive Review on Synthesis and Recent Advances.

Authors:  Reema Narayan; Usha Y Nayak; Ashok M Raichur; Sanjay Garg
Journal:  Pharmaceutics       Date:  2018-08-06       Impact factor: 6.321

4.  A Multifunctional Nanocrystalline CaF2:Tm,Yb@mSiO2 System for Dual-Triggered and Optically Monitored Doxorubicin Delivery.

Authors:  Yangyang Li; Yurong Zhou; Tongxu Gu; Gang Wang; Zhaohui Ren; Wenjian Weng; Xiang Li; Gaorong Han; Chuanbin Mao
Journal:  Part Part Syst Charact       Date:  2016-10-20       Impact factor: 3.310

Review 5.  Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery: an update.

Authors:  Rafael R Castillo; Daniel Lozano; Blanca González; Miguel Manzano; Isabel Izquierdo-Barba; María Vallet-Regí
Journal:  Expert Opin Drug Deliv       Date:  2019-04-22       Impact factor: 6.648

Review 6.  Mesoporous silica nanoparticles for stimuli-responsive controlled drug delivery: advances, challenges, and outlook.

Authors:  Yuanhui Song; Yihong Li; Qien Xu; Zhe Liu
Journal:  Int J Nanomedicine       Date:  2016-12-20

7.  Intracellular pH-responsive and rituximab-conjugated mesoporous silica nanoparticles for targeted drug delivery to lymphoma B cells.

Authors:  Shoubing Zhou; Dan Wu; Xiaodong Yin; Xiaoxiao Jin; Xiu Zhang; Shiya Zheng; Cailian Wang; Yanwen Liu
Journal:  J Exp Clin Cancer Res       Date:  2017-02-06

Review 8.  Controlled drug delivery systems for cancer based on mesoporous silica nanoparticles.

Authors:  Nerea Iturrioz-Rodríguez; Miguel A Correa-Duarte; Mónica L Fanarraga
Journal:  Int J Nanomedicine       Date:  2019-05-08

9.  Construction of A Triple-Stimuli-Responsive System Based on Cerium Oxide Coated Mesoporous Silica Nanoparticles.

Authors:  Jia Wen; Kui Yang; Yongqian Xu; Hongjuan Li; Fengyu Liu; Shiguo Sun
Journal:  Sci Rep       Date:  2016-12-12       Impact factor: 4.379

10.  EDTA-Modified 17β-Estradiol-Laden Upconversion Nanocomposite for Bone-Targeted Hormone Replacement Therapy for Osteoporosis.

Authors:  Xiaoting Chen; Xingjun Zhu; Yan Hu; Wei Yuan; Xiaochen Qiu; Tianyuan Jiang; Chao Xia; Liqin Xiong; Fuyou Li; Yanhong Gao
Journal:  Theranostics       Date:  2020-02-10       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.